Replimune (REPL) EBIT Margin (2017 - 2018)
Powered by 
Analysis
Replimune (REPL) EBIT Margin (2017 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.69 Bn | 1,103.27 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 616.29 Bn | 534.82 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 500.86 Bn | 473.97 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 366.77 Bn | 321.15 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 235.52 Bn | 190.92 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.49 Bn | 164.69 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 28.37% |
| 10 | Replimune | 1.14 Bn | 87.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -1,149.32% |
| Sep 30, 2018 | -1,069.88% |
| Jun 30, 2018 | -2,589.87% |
| Dec 31, 2017 | -14,787.50% |
| Sep 30, 2017 | -42,560.00% |
| Jun 30, 2017 | -10,586.67% |
API Access
Replimune EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();